As of 2024-12-12, the Intrinsic Value of Bruker Corp (BRKR) is
75.54 USD. This BRKR valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 59.65 USD, the upside of Bruker Corp is
26.60%.
The range of the Intrinsic Value is 50.28 - 138.57 USD
75.54 USD
Intrinsic Value
BRKR Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
50.28 - 138.57 |
75.54 |
26.6% |
| DCF (Growth 10y) |
63.59 - 159.57 |
91.25 |
53.0% |
| DCF (EBITDA 5y) |
106.78 - 128.98 |
121.25 |
103.3% |
| DCF (EBITDA 10y) |
117.84 - 153.64 |
138.32 |
131.9% |
| Fair Value |
46.83 - 46.83 |
46.83 |
-21.49% |
| P/E |
61.18 - 104.85 |
83.51 |
40.0% |
| EV/EBITDA |
52.99 - 100.76 |
76.25 |
27.8% |
| EPV |
8.14 - 14.73 |
11.44 |
-80.8% |
| DDM - Stable |
18.08 - 53.34 |
35.71 |
-40.1% |
| DDM - Multi |
46.51 - 105.90 |
64.55 |
8.2% |
BRKR Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
9,042.94 |
| Beta |
1.29 |
| Outstanding shares (mil) |
151.60 |
| Enterprise Value (mil) |
11,192.14 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.09% |
| Cost of Debt |
4.28% |
| WACC |
8.34% |